Nykode Therapeutics ASA (NYKD) — Cash Flow Quality Index
Nykode Therapeutics ASA (NYKD) has a Cash Flow Quality Index of 1.91x as of December 2021. Operating cash flow of Nkr180.92 Million exceeds net income of Nkr94.90 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Nykode Therapeutics ASA to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nykode Therapeutics ASA Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Nykode Therapeutics ASA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Nykode Therapeutics ASA cash flow conversion.
Annual Cash Flow Quality Index for Nykode Therapeutics ASA (2020–2020)
Year-by-year earnings quality comparison for Nykode Therapeutics ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.00x | Nkr180.27 Million | Nkr180.91 Million | — |